GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » EBITDA Margin %

Medinet Co (TSE:2370) EBITDA Margin % : -224.84% (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medinet Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medinet Co's EBITDA for the three months ended in Mar. 2024 was 円-340.5 Mil. Medinet Co's Revenue for the three months ended in Mar. 2024 was 円151.5 Mil. Therefore, Medinet Co's EBITDA margin for the quarter that ended in Mar. 2024 was -224.84%.


Medinet Co EBITDA Margin % Historical Data

The historical data trend for Medinet Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinet Co EBITDA Margin % Chart

Medinet Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -86.98 -105.83 -180.35 -201.13 -150.75

Medinet Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -257.83 -231.01 -117.62 -224.84 -

Competitive Comparison of Medinet Co's EBITDA Margin %

For the Biotechnology subindustry, Medinet Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinet Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medinet Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medinet Co's EBITDA Margin % falls into.



Medinet Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medinet Co's EBITDA Margin % for the fiscal year that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2024 )/Revenue (A: Sep. 2024 )
=-1158.503/768.501
=-150.75 %

Medinet Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-340.54/151.458
=-224.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medinet Co  (TSE:2370) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Medinet Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Medinet Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medinet Co Business Description

Traded in Other Exchanges
N/A
Address
2-3-12 Shin-Yokohama, Shin-Yokohama Square Building, 14 Floor, Kohoku-ku, Yokohama, JPN, 222-0033
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.

Medinet Co Headlines

No Headlines